PL357367A1 - Mycophenolate mofetil in association with peg-ifn-alpha - Google Patents

Mycophenolate mofetil in association with peg-ifn-alpha

Info

Publication number
PL357367A1
PL357367A1 PL00357367A PL35736700A PL357367A1 PL 357367 A1 PL357367 A1 PL 357367A1 PL 00357367 A PL00357367 A PL 00357367A PL 35736700 A PL35736700 A PL 35736700A PL 357367 A1 PL357367 A1 PL 357367A1
Authority
PL
Poland
Prior art keywords
ifn
peg
alpha
association
mycophenolate mofetil
Prior art date
Application number
PL00357367A
Other languages
English (en)
Polish (pl)
Inventor
Mary Catherine Graves
Stephen Christopher Pappas
Friederike Zahm
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL357367A1 publication Critical patent/PL357367A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL00357367A 1999-08-13 2000-08-08 Mycophenolate mofetil in association with peg-ifn-alpha PL357367A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99115950 1999-08-13
US18790700P 2000-03-08 2000-03-08
PCT/EP2000/007666 WO2001012214A2 (en) 1999-08-13 2000-08-08 MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a)

Publications (1)

Publication Number Publication Date
PL357367A1 true PL357367A1 (en) 2004-07-26

Family

ID=29762814

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00357367A PL357367A1 (en) 1999-08-13 2000-08-08 Mycophenolate mofetil in association with peg-ifn-alpha

Country Status (14)

Country Link
EP (1) EP1220683A2 (xx)
JP (1) JP2003507339A (xx)
CN (1) CN1368887A (xx)
AU (1) AU7408200A (xx)
BR (1) BR0013252A (xx)
CA (1) CA2380653A1 (xx)
HU (1) HUP0202525A3 (xx)
MX (1) MXPA02001296A (xx)
PE (1) PE20010490A1 (xx)
PL (1) PL357367A1 (xx)
RU (1) RU2002105485A (xx)
TR (1) TR200200401T2 (xx)
WO (1) WO2001012214A2 (xx)
ZA (1) ZA200200280B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307553D0 (en) * 2003-04-01 2003-05-07 Novartis Ag Organic compounds
DE602005013922D1 (de) 2004-02-24 2009-05-28 Japan Tobacco Inc Kondensierte heterotetracyclische verbindungen und deren verwendung als hcv-polymerase-inhibitor
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
KR20070045244A (ko) * 2004-08-12 2007-05-02 쉐링 코포레이션 안정한 페길화된 인터페론 제형
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
US8017612B2 (en) 2006-04-18 2011-09-13 Japan Tobacco Inc. Piperazine compound and use thereof as a HCV polymerase inhibitor
WO2010110503A1 (ko) * 2009-03-27 2010-09-30 주식회사 중외제약 인터페론-알파 및 세포질 잔류성 세포막 투과 펩타이드를 포함하는 IFN-α 융합 단백질
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
CH707029B1 (de) 2011-10-21 2015-03-13 Abbvie Inc Verfahren zur Behandlung von HCV, umfassend mindestens zwei direkt wirkende antivirale Wirkstoffe, Ribavirin, aber nicht Interferon.
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
EP2583680A3 (en) 2011-10-21 2013-06-12 Abbvie Inc. Mono (PSI-7977) or combination treatment of DAAs for use in treating HCV
EP3215193B1 (en) * 2014-11-06 2023-10-04 PharmaEssentia Corporation Dosage regimen for pegylated interferon
EA201892448A1 (ru) 2016-04-28 2019-06-28 Эмори Юниверсити Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
MY125300A (en) * 1999-02-26 2006-07-31 Inst Of Molecular And Cell Biology Synergistic combination for treatment of viral-mediated diseases

Also Published As

Publication number Publication date
WO2001012214A2 (en) 2001-02-22
JP2003507339A (ja) 2003-02-25
ZA200200280B (en) 2003-04-11
HUP0202525A2 (hu) 2002-11-28
BR0013252A (pt) 2002-04-16
CA2380653A1 (en) 2001-02-22
CN1368887A (zh) 2002-09-11
WO2001012214A3 (en) 2001-10-04
AU7408200A (en) 2001-03-13
PE20010490A1 (es) 2001-04-27
TR200200401T2 (tr) 2002-06-21
HUP0202525A3 (en) 2003-11-28
MXPA02001296A (es) 2002-07-22
EP1220683A2 (en) 2002-07-10
RU2002105485A (ru) 2004-01-27

Similar Documents

Publication Publication Date Title
AU141486S (en) Bottle with top
ZA200107409B (en) Fuel composition.
EP1409843A4 (en) ENGINE
GB9923857D0 (en) Thrust cap
HK1044016A1 (en) Cellulignin fuel
PL357367A1 (en) Mycophenolate mofetil in association with peg-ifn-alpha
IL147612A0 (en) MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PREG-IFN-α
EP1257619A4 (en) FUEL COMPOSITION
GB9927122D0 (en) Improvements in swashplate design
GB9929805D0 (en) Fuel composition
GB9929806D0 (en) Fuel composition
TW401839U (en) Improved top structure
GB9908908D0 (en) Diesel co-production
GB2345517B (en) Engine
GB9912734D0 (en) Seating arrangements
GB2345732B (en) Propeller
IL133796A0 (en) Fuel cap
PL332759A1 (en) Drawing engine
GB9912118D0 (en) Silencer-jet engine
GB9923859D0 (en) Improved engine
GB9810535D0 (en) Drinks can with retractable straw
GB9926319D0 (en) Improvements in or relating to seating arrangements
GB9918729D0 (en) Improvements in life jackets
AU144734S (en) Catamaran
GB9901284D0 (en) Fuel fabrication

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)